• UroGen Pharma Ltd. (NASDAQ:URGN) Receives Average Rating of "Buy" from Analysts

    المصدر: Buzz FX / 19 فبراير 2025 02:36:11   America/New_York


    UroGen Pharma Ltd. (NASDAQ:URGN) Receives Average Rating of "Buy" from Analysts Written by MarketBeat February 19, 2025 Share Link copied to clipboard. Shares of UroGen Pharma Ltd. ( NASDAQ:URGN - Get Free Report ) have been assigned an ave
    Read more...
شارك على،